Literature DB >> 33296018

[Microbiological and infectious disease aspects of postoperative endophthalmitis].

Sören L Becker1, Lukas Bisorca-Gassendorf2, Karl T Boden2, Sami Al-Nawaiseh2, Kai Januschowski2,3, Berthold Seitz4, Núria Pérez Guerra2.   

Abstract

Infectious postoperative or postinjection endophthalmitis is a medical emergency. Gram-positive bacteria, such as staphylococci, streptococci and enterococci are the predominant causative agents, whereas Gram-negative pathogens (e.g. Klebsiella pneumoniae, Pseudomonas aeruginosa) and fungi account for a minority of cases. Using modern diagnostic tools, which include polymerase chain reaction-based assays in addition to Gram staining and agar culturing, a causal agent can be detected in the majority of cases, which enables a targeted treatment and estimation of the prognosis. Endophthalmitis is treated with intravitreal and often also intravenous administration of antibiotics, with the combination of vancomycin and ceftazidime being most commonly used. This article presents and summarizes recent developments in the microbiological etiology and diagnostics of endophthalmitis as well as treatment options and perioperative antibiotic prophylaxis in the light of emerging resistance patterns.

Entities:  

Keywords:  Antibiotics; Diagnosis; Gram-negative bacteria; Infection; Treatment

Year:  2021        PMID: 33296018     DOI: 10.1007/s00347-020-01287-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  2 in total

1.  Authors' Response.

Authors:  Andrzej Grzybowski; Piotr Brona; Luis Zeman; Michael W Stewart
Journal:  Surv Ophthalmol       Date:  2020-11-23       Impact factor: 6.048

2.  Clinical Characteristics and Prognosis of Adult Orbital Cellulitis in a Tertiary General Hospital.

Authors:  Bangtao Yao; Yuhua Ding; Xiaogui Zhao; Bei Wang; Gang Liu; Fei Wang
Journal:  J Ophthalmol       Date:  2020-12-08       Impact factor: 1.909

  2 in total
  1 in total

Review 1.  [Treatment of postoperative endophthalmitis : Operate or only inject?]

Authors:  L Mautone; C Skevas; M S Spitzer
Journal:  Ophthalmologe       Date:  2021-02-10       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.